SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study

Abstract Epithelial ovarian cancer (EOC) is the most common cause of death from gynecological cancer. The outcomes of EOC are complicated, as it is often diagnosed late and comprises several heterogenous subtypes. As such, upfront treatment can be highly challenging. Although many significant advanc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mariola Olkowicz, Hernando Rosales-Solano, Vathany Kulasingam, Janusz Pawliszyn
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/341dfd9c3f7b4eae802b5541e5c42ac7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:341dfd9c3f7b4eae802b5541e5c42ac7
record_format dspace
spelling oai:doaj.org-article:341dfd9c3f7b4eae802b5541e5c42ac72021-11-21T12:25:21ZSPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study10.1038/s41598-021-00802-92045-2322https://doaj.org/article/341dfd9c3f7b4eae802b5541e5c42ac72021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-00802-9https://doaj.org/toc/2045-2322Abstract Epithelial ovarian cancer (EOC) is the most common cause of death from gynecological cancer. The outcomes of EOC are complicated, as it is often diagnosed late and comprises several heterogenous subtypes. As such, upfront treatment can be highly challenging. Although many significant advances in EOC management have been made over the past several decades, further work must be done to develop early detection tools capable of distinguishing between the various EOC subtypes. In this paper, we present a sophisticated analytical pipeline based on solid-phase microextraction (SPME) and three orthogonal LC/MS acquisition modes that facilitates the comprehensive mapping of a wide range of analytes in serum samples from patients with EOC. PLS-DA multivariate analysis of the metabolomic data was able to provide clear discrimination between all four main EOC subtypes: serous, endometrioid, clear cell, and mucinous carcinomas. The prognostic performance of discriminative metabolites and lipids was confirmed via multivariate receiver operating characteristic (ROC) analysis (AUC value > 88% with 20 features). Further pathway analysis using the top 57 dysregulated metabolic features showed distinct differences in amino acid, lipid, and steroids metabolism among the four EOC subtypes. Thus, metabolomic profiling can serve as a powerful tool for complementing histology in classifying EOC subtypes.Mariola OlkowiczHernando Rosales-SolanoVathany KulasingamJanusz PawliszynNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mariola Olkowicz
Hernando Rosales-Solano
Vathany Kulasingam
Janusz Pawliszyn
SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
description Abstract Epithelial ovarian cancer (EOC) is the most common cause of death from gynecological cancer. The outcomes of EOC are complicated, as it is often diagnosed late and comprises several heterogenous subtypes. As such, upfront treatment can be highly challenging. Although many significant advances in EOC management have been made over the past several decades, further work must be done to develop early detection tools capable of distinguishing between the various EOC subtypes. In this paper, we present a sophisticated analytical pipeline based on solid-phase microextraction (SPME) and three orthogonal LC/MS acquisition modes that facilitates the comprehensive mapping of a wide range of analytes in serum samples from patients with EOC. PLS-DA multivariate analysis of the metabolomic data was able to provide clear discrimination between all four main EOC subtypes: serous, endometrioid, clear cell, and mucinous carcinomas. The prognostic performance of discriminative metabolites and lipids was confirmed via multivariate receiver operating characteristic (ROC) analysis (AUC value > 88% with 20 features). Further pathway analysis using the top 57 dysregulated metabolic features showed distinct differences in amino acid, lipid, and steroids metabolism among the four EOC subtypes. Thus, metabolomic profiling can serve as a powerful tool for complementing histology in classifying EOC subtypes.
format article
author Mariola Olkowicz
Hernando Rosales-Solano
Vathany Kulasingam
Janusz Pawliszyn
author_facet Mariola Olkowicz
Hernando Rosales-Solano
Vathany Kulasingam
Janusz Pawliszyn
author_sort Mariola Olkowicz
title SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
title_short SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
title_full SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
title_fullStr SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
title_full_unstemmed SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
title_sort spme-lc/ms-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/341dfd9c3f7b4eae802b5541e5c42ac7
work_keys_str_mv AT mariolaolkowicz spmelcmsbasedserummetabolomicphenotypingfordistinguishingovariancancerhistologicsubtypesapilotstudy
AT hernandorosalessolano spmelcmsbasedserummetabolomicphenotypingfordistinguishingovariancancerhistologicsubtypesapilotstudy
AT vathanykulasingam spmelcmsbasedserummetabolomicphenotypingfordistinguishingovariancancerhistologicsubtypesapilotstudy
AT januszpawliszyn spmelcmsbasedserummetabolomicphenotypingfordistinguishingovariancancerhistologicsubtypesapilotstudy
_version_ 1718418998519922688